至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Acoustofluidic Synthesis of Particulate Nanomaterials

Adv Sci (Weinh). 2019; 
Huang PH, Zhao S, Bachman H, Nama N, Li Z, Chen C, Yang S, Wu M, Zhang SP, Huang TJ
Products/Services Used Details Operation
Recombinant Proteins FITC-dextran, tetrathiafulvalene, hydrogen tetrachloroaurate (HAuCl4), acetonitrile, low-molecular weight chitosan, adenosine triphosphate, sodium hydroxide (NaOH), glacial acetic acid, purified water (H2O), Zn(OAc)2 (≥99%), and 2-methylimidazol (≥99%) were purchased from SigmaAldrich (St. Louis, MO, USA). Lipofectamine 2000 and pcDNA3-EGFP were purchased from Invitrogen (Carlsbad, CA, USA) and GenScript (Piscataway, NJ, USA), respectively. Get A Quote

摘要

Synthesis of nanoparticles and particulate nanomaterials with tailored properties is a central step toward many applications ranging from energy conversion and imaging/display to biosensing and nanomedicine. While existing microfluidics-based synthesis methods offer precise control over the synthesis process, most of them rely on passive, partial mixing of reagents, which limits their applicability and potentially, adversely alter the properties of synthesized products. Here, an acoustofluidic (i.e., the fusion of acoustic and microfluidics) synthesis platform is reported to synthesize nanoparticles and nanomaterials in a controllable, reproducible manner through acoustic-streaming-based active mixing of reagen... More

关键词